-
1
-
-
0028929803
-
Angiogenesis in cancer, vascular, rheumatoid and other disease
-
Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995, 1:27-31.
-
(1995)
Nat Med
, vol.1
, pp. 27-31
-
-
Folkman, J.1
-
2
-
-
0034648765
-
Angiogenesis in cancer and other diseases
-
Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000, 407:249-57.
-
(2000)
Nature
, vol.407
, pp. 249-257
-
-
Carmeliet, P.1
Jain, R.K.2
-
3
-
-
0033454716
-
Anticancer drug targets: approaching angiogenesis
-
Keshet E, Ben-Sasson SA. Anticancer drug targets: approaching angiogenesis. J Clin Invest 1999, 104:1497-501.
-
(1999)
J Clin Invest
, vol.104
, pp. 1497-1501
-
-
Keshet, E.1
Ben-Sasson, S.A.2
-
4
-
-
18144364350
-
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis
-
Presta M, Dell'Era P, Mitola S. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev 2005, 16:159-78.
-
(2005)
Cytokine Growth Factor Rev
, vol.16
, pp. 159-178
-
-
Presta, M.1
Dell'Era, P.2
Mitola, S.3
-
5
-
-
0023157363
-
Angiogenic factors
-
Folkman J, Klagsbrun M. Angiogenic factors. Science 1987, 235:442-7.
-
(1987)
Science
, vol.235
, pp. 442-447
-
-
Folkman, J.1
Klagsbrun, M.2
-
7
-
-
0034127430
-
Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis
-
Gerwins P, Skoldenberg E, Claesson-Welsh L. Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis. Crit Rev Oncol Hematol 2000, 34:185-94.
-
(2000)
Crit Rev Oncol Hematol
, vol.34
, pp. 185-194
-
-
Gerwins, P.1
Skoldenberg, E.2
Claesson-Welsh, L.3
-
8
-
-
34447253095
-
Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies
-
Rusnati M, Presta M. Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies. Curr Pharm Des 2007, 13:2025-44.
-
(2007)
Curr Pharm Des
, vol.13
, pp. 2025-2044
-
-
Rusnati, M.1
Presta, M.2
-
9
-
-
0030855812
-
Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth
-
Wang Y, Becker D. Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth. Nat Med 1997, 3:887-93.
-
(1997)
Nat Med
, vol.3
, pp. 887-893
-
-
Wang, Y.1
Becker, D.2
-
10
-
-
0034283023
-
Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts
-
Rofstad EK, Halsor EF. Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts. Cancer Res 2000, 60:4932-8.
-
(2000)
Cancer Res
, vol.60
, pp. 4932-4938
-
-
Rofstad, E.K.1
Halsor, E.F.2
-
11
-
-
0033556802
-
Signal transduction by fibroblast growth factor receptors
-
Klint P, Claesson-Welsh L. Signal transduction by fibroblast growth factor receptors. Front Biosci 1999, 4:D165-77.
-
(1999)
Front Biosci
, vol.4
-
-
Klint, P.1
Claesson-Welsh, L.2
-
12
-
-
0028825543
-
Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors
-
Schlessinger J, Lax I, Lemmon M. Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors. Cell 1995, 83:357-60.
-
(1995)
Cell
, vol.83
, pp. 357-360
-
-
Schlessinger, J.1
Lax, I.2
Lemmon, M.3
-
13
-
-
0029704210
-
Interaction of angiogenic basic fibroblast growth factor with endothelial cell heparan sulfate proteoglycans. Biological implications in neovascularization
-
Rusnati M, Presta M. Interaction of angiogenic basic fibroblast growth factor with endothelial cell heparan sulfate proteoglycans. Biological implications in neovascularization. Int J Clin Lab Res 1996, 26:15-23.
-
(1996)
Int J Clin Lab Res
, vol.26
, pp. 15-23
-
-
Rusnati, M.1
Presta, M.2
-
14
-
-
0033635299
-
Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization
-
Schlessinger J, Plotnikov AN, Ibrahimi OA. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol Cell 2000, 6:743-50.
-
(2000)
Mol Cell
, vol.6
, pp. 743-750
-
-
Schlessinger, J.1
Plotnikov, A.N.2
Ibrahimi, O.A.3
-
15
-
-
0028223040
-
In vitro inhibition of the actions of basic FGF by a novel 16 amino acid peptide
-
Cosic I, Drummond AE, Underwood JR. In vitro inhibition of the actions of basic FGF by a novel 16 amino acid peptide. Mol Cell Biochem 1994, 130:1-9.
-
(1994)
Mol Cell Biochem
, vol.130
, pp. 1-9
-
-
Cosic, I.1
Drummond, A.E.2
Underwood, J.R.3
-
16
-
-
0031011861
-
A 10-amino acid sequence of fibroblast growth factor 2 is sufficient for its mitogenic activity on neural progenitor cells
-
Ray J, Baird A, Gage FH. A 10-amino acid sequence of fibroblast growth factor 2 is sufficient for its mitogenic activity on neural progenitor cells. Proc Natl Acad Sci USA 1997, 94:7047-52.
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, pp. 7047-7052
-
-
Ray, J.1
Baird, A.2
Gage, F.H.3
-
17
-
-
0035941197
-
Identification of an N-cadherin motif that can interact with the fibroblast growth factor receptor and is required for axonal growth
-
Williams EJ, Williams G, Howell FV. Identification of an N-cadherin motif that can interact with the fibroblast growth factor receptor and is required for axonal growth. J Biol Chem 2001, 276:43879-86.
-
(2001)
J Biol Chem
, vol.276
, pp. 43879-43886
-
-
Williams, E.J.1
Williams, G.2
Howell, F.V.3
-
18
-
-
10744221752
-
Structural basis for a direct interaction between FGFR1 and NCAM and evidence for a regulatory role of ATP
-
Kiselyov VV, Skladchikova G, Hinsby AM. Structural basis for a direct interaction between FGFR1 and NCAM and evidence for a regulatory role of ATP. Structure 2003, 11:691-701.
-
(2003)
Structure
, vol.11
, pp. 691-701
-
-
Kiselyov, V.V.1
Skladchikova, G.2
Hinsby, A.M.3
-
19
-
-
20844449232
-
An NCAM-derived FGF-receptor agonist, the FGL-peptide, induces neurite outgrowth and neuronal survival in primary rat neurons
-
Neiiendam JL, Kohler LB, Christensen C. An NCAM-derived FGF-receptor agonist, the FGL-peptide, induces neurite outgrowth and neuronal survival in primary rat neurons. J Neurochem 2004, 91:920-35.
-
(2004)
J Neurochem
, vol.91
, pp. 920-935
-
-
Neiiendam, J.L.1
Kohler, L.B.2
Christensen, C.3
-
20
-
-
26844476866
-
A peptide from the first fibronectin domain of NCAM acts as an inverse agonist and stimulates FGF receptor activation, neurite outgrowth and survival
-
Anderson AA, Kendal CE, Garcia-Maya M. A peptide from the first fibronectin domain of NCAM acts as an inverse agonist and stimulates FGF receptor activation, neurite outgrowth and survival. J Neurochem 2005, 95:570-83.
-
(2005)
J Neurochem
, vol.95
, pp. 570-583
-
-
Anderson, A.A.1
Kendal, C.E.2
Garcia-Maya, M.3
-
21
-
-
77949910104
-
NCAM mimetic peptides: an update
-
Berezin V, Bock E. NCAM mimetic peptides: an update. Adv Exp Med Biol 2010, 663:337-53.
-
(2010)
Adv Exp Med Biol
, vol.663
, pp. 337-353
-
-
Berezin, V.1
Bock, E.2
-
22
-
-
77949878380
-
Synthetic NCAM-derived ligands of the fibroblast growth factor receptor
-
Hansen SM, Li S, Bock E. Synthetic NCAM-derived ligands of the fibroblast growth factor receptor. Adv Exp Med Biol 2010, 663:355-72.
-
(2010)
Adv Exp Med Biol
, vol.663
, pp. 355-372
-
-
Hansen, S.M.1
Li, S.2
Bock, E.3
-
23
-
-
0035291003
-
A short peptide domain of platelet factor 4 blocks angiogenic key events induced by FGF-2
-
Hagedorn M, Zilberberg L, Lozano RM. A short peptide domain of platelet factor 4 blocks angiogenic key events induced by FGF-2. FASEB J 2001, 15:550-2.
-
(2001)
FASEB J
, vol.15
, pp. 550-552
-
-
Hagedorn, M.1
Zilberberg, L.2
Lozano, R.M.3
-
24
-
-
0037424489
-
Identification of a novel domain of fibroblast growth factor 2 controlling its angiogenic properties
-
Facchiano A, Russo K, Facchiano AM. Identification of a novel domain of fibroblast growth factor 2 controlling its angiogenic properties. J Biol Chem 2003, 278:8751-60.
-
(2003)
J Biol Chem
, vol.278
, pp. 8751-8760
-
-
Facchiano, A.1
Russo, K.2
Facchiano, A.M.3
-
25
-
-
77951970480
-
Isolation of a novel basic FGF-binding peptide with potent antiangiogenetic activity
-
Wu X, Yan Q, Huang Y. Isolation of a novel basic FGF-binding peptide with potent antiangiogenetic activity. J Cell Mol Med 2010, 14:351-6.
-
(2010)
J Cell Mol Med
, vol.14
, pp. 351-356
-
-
Wu, X.1
Yan, Q.2
Huang, Y.3
-
26
-
-
17644423119
-
Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility
-
Garlanda C, Bottazzi B, Bastone A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol 2005, 23:337-66.
-
(2005)
Annu Rev Immunol
, vol.23
, pp. 337-366
-
-
Garlanda, C.1
Bottazzi, B.2
Bastone, A.3
-
27
-
-
34548189432
-
Role of the soluble pattern recognition receptor PTX3 in vascular biology
-
Presta M, Camozzi M, Salvatori G. Role of the soluble pattern recognition receptor PTX3 in vascular biology. J Cell Mol Med 2007, 11:723-38.
-
(2007)
J Cell Mol Med
, vol.11
, pp. 723-738
-
-
Presta, M.1
Camozzi, M.2
Salvatori, G.3
-
28
-
-
2542604364
-
Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis
-
Rusnati M, Camozzi M, Moroni E. Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis. Blood 2004, 104:92-9.
-
(2004)
Blood
, vol.104
, pp. 92-99
-
-
Rusnati, M.1
Camozzi, M.2
Moroni, E.3
-
29
-
-
24144480882
-
Pentraxin 3 inhibits fibroblast growth factor 2-dependent activation of smooth muscle cells in vitro and neointima formation in vivo
-
Camozzi M, Zacchigna S, Rusnati M. Pentraxin 3 inhibits fibroblast growth factor 2-dependent activation of smooth muscle cells in vitro and neointima formation in vivo. Arterioscler Thromb Vasc Biol 2005, 25:1837-42.
-
(2005)
Arterioscler Thromb Vasc Biol
, vol.25
, pp. 1837-1842
-
-
Camozzi, M.1
Zacchigna, S.2
Rusnati, M.3
-
30
-
-
33747336999
-
Identification of an antiangiogenic FGF2-binding site in the N terminus of the soluble pattern recognition receptor PTX3
-
Camozzi M, Rusnati M, Bugatti A. Identification of an antiangiogenic FGF2-binding site in the N terminus of the soluble pattern recognition receptor PTX3. J Biol Chem 2006, 281:22605-13.
-
(2006)
J Biol Chem
, vol.281
, pp. 22605-22613
-
-
Camozzi, M.1
Rusnati, M.2
Bugatti, A.3
-
31
-
-
0025846960
-
A six-amino acid deletion in basic fibroblast growth factor dissociates its mitogenic activity from its plasminogen activator-inducing capacity
-
Isacchi A, Statuto M, Chiesa R. A six-amino acid deletion in basic fibroblast growth factor dissociates its mitogenic activity from its plasminogen activator-inducing capacity. Proc Natl Acad Sci USA 1991, 88:2628-32.
-
(1991)
Proc Natl Acad Sci USA
, vol.88
, pp. 2628-2632
-
-
Isacchi, A.1
Statuto, M.2
Chiesa, R.3
-
32
-
-
33751519263
-
High-level expression and efficient purification of recombinant human long pentraxin PTX3 in Chinese hamster ovary cells
-
Rivieccio V, Esposito A, Bellofiore P. High-level expression and efficient purification of recombinant human long pentraxin PTX3 in Chinese hamster ovary cells. Protein Expr Purif 2007, 51:49-58.
-
(2007)
Protein Expr Purif
, vol.51
, pp. 49-58
-
-
Rivieccio, V.1
Esposito, A.2
Bellofiore, P.3
-
33
-
-
0025823018
-
Genetic analysis of proteoglycan structure, function and metabolism
-
Esko JD. Genetic analysis of proteoglycan structure, function and metabolism. Curr Opin Cell Biol 1991, 3:805-16.
-
(1991)
Curr Opin Cell Biol
, vol.3
, pp. 805-816
-
-
Esko, J.D.1
-
34
-
-
0033061257
-
Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds
-
Liekens S, Leali D, Neyts J. Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds. Mol Pharmacol 1999, 56:204-13.
-
(1999)
Mol Pharmacol
, vol.56
, pp. 204-213
-
-
Liekens, S.1
Leali, D.2
Neyts, J.3
-
35
-
-
0029876408
-
A distinct basic fibroblast growth factor (FGF-2)/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells
-
Rusnati M, Dell'Era P, Urbinati C. A distinct basic fibroblast growth factor (FGF-2)/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells. Mol Biol Cell 1996, 7:369-81.
-
(1996)
Mol Biol Cell
, vol.7
, pp. 369-381
-
-
Rusnati, M.1
Dell'Era, P.2
Urbinati, C.3
-
36
-
-
0032721632
-
Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2
-
Ribatti D, Gualandris A, Belleri M. Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2. J Pathol 1999, 189:590-9.
-
(1999)
J Pathol
, vol.189
, pp. 590-599
-
-
Ribatti, D.1
Gualandris, A.2
Belleri, M.3
-
37
-
-
0024796872
-
Basic fibroblast growth factor: production, mitogenic response, and post-receptor signal transduction in cultured normal and transformed fetal bovine aortic endothelial cells
-
Presta M, Maier JA, Rusnati M. Basic fibroblast growth factor: production, mitogenic response, and post-receptor signal transduction in cultured normal and transformed fetal bovine aortic endothelial cells. J Cell Physiol 1989, 141:517-26.
-
(1989)
J Cell Physiol
, vol.141
, pp. 517-526
-
-
Presta, M.1
Maier, J.A.2
Rusnati, M.3
-
38
-
-
0035851094
-
Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivatives
-
Leali D, Belleri M, Urbinati C. Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivatives. J Biol Chem 2001, 276:37900-8.
-
(2001)
J Biol Chem
, vol.276
, pp. 37900-37908
-
-
Leali, D.1
Belleri, M.2
Urbinati, C.3
-
39
-
-
34447277610
-
Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of HIV-1 Tat and gp120 proteins
-
Bugatti A, Urbinati C, Ravelli C. Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of HIV-1 Tat and gp120 proteins. Antimicrob Agents Chemother 2007, 51:2337-45.
-
(2007)
Antimicrob Agents Chemother
, vol.51
, pp. 2337-2345
-
-
Bugatti, A.1
Urbinati, C.2
Ravelli, C.3
-
40
-
-
0032789946
-
A comparison of two controlled-release delivery systems for the delivery of amiloride to control angiogenesis
-
Knoll A, Schmidt S, Chapman M. A comparison of two controlled-release delivery systems for the delivery of amiloride to control angiogenesis. Microvasc Res 1999, 58:1-9.
-
(1999)
Microvasc Res
, vol.58
, pp. 1-9
-
-
Knoll, A.1
Schmidt, S.2
Chapman, M.3
-
41
-
-
39149110311
-
The zebrafish/tumor xenograft angiogenesis assay
-
Nicoli S, Presta M. The zebrafish/tumor xenograft angiogenesis assay. Nat Protoc 2007, 2:2918-23.
-
(2007)
Nat Protoc
, vol.2
, pp. 2918-2923
-
-
Nicoli, S.1
Presta, M.2
-
42
-
-
34248193216
-
Mammalian tumor xenografts induce neovascularization in zebrafish embryos
-
Nicoli S, Ribatti D, Cotelli F. Mammalian tumor xenografts induce neovascularization in zebrafish embryos. Cancer Res 2007, 67:2927-31.
-
(2007)
Cancer Res
, vol.67
, pp. 2927-2931
-
-
Nicoli, S.1
Ribatti, D.2
Cotelli, F.3
-
43
-
-
0000905788
-
Zebrafish angiogenesis: a new model for drug screening
-
Serbedzija GN, Flynn E, Willett CE. Zebrafish angiogenesis: a new model for drug screening. Angiogenesis 1999, 3:353-9.
-
(1999)
Angiogenesis
, vol.3
, pp. 353-359
-
-
Serbedzija, G.N.1
Flynn, E.2
Willett, C.E.3
-
44
-
-
5144233105
-
MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy
-
Bax D, Davis GD. MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy. J Magn Reson 1985, 65:355-60.
-
(1985)
J Magn Reson
, vol.65
, pp. 355-360
-
-
Bax, D.1
Davis, G.D.2
-
45
-
-
79960698472
-
Water suppression that works. Excitation sculpting using arbitrary wave-forms and pulsed-field gradients
-
Hwang TL, Shaka AJ. Water suppression that works. Excitation sculpting using arbitrary wave-forms and pulsed-field gradients. J Magn Reson Series A 1995, 112:275-9.
-
(1995)
J Magn Reson Series A
, vol.112
, pp. 275-279
-
-
Hwang, T.L.1
Shaka, A.J.2
-
46
-
-
0034823890
-
Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor
-
Mayer M, Meyer B. Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor. J Am Chem Soc 2001, 123:6108-17.
-
(2001)
J Am Chem Soc
, vol.123
, pp. 6108-6117
-
-
Mayer, M.1
Meyer, B.2
-
47
-
-
15844368097
-
Receptor specificity of the fibroblast growth factor family
-
Ornitz DM, Xu J, Colvin JS. Receptor specificity of the fibroblast growth factor family. J Biol Chem 1996, 271:15292-7.
-
(1996)
J Biol Chem
, vol.271
, pp. 15292-15297
-
-
Ornitz, D.M.1
Xu, J.2
Colvin, J.S.3
-
48
-
-
34250640742
-
The gelatin sponge-chorioallantoic membrane assay
-
Ribatti D, Nico B, Vacca A. The gelatin sponge-chorioallantoic membrane assay. Nat Protoc 2006, 1:85-91.
-
(2006)
Nat Protoc
, vol.1
, pp. 85-91
-
-
Ribatti, D.1
Nico, B.2
Vacca, A.3
-
49
-
-
0043032424
-
The effect of relaxation on the epitope mapping by saturation transfer difference NMR
-
Yan J, Kline AD, Mo H. The effect of relaxation on the epitope mapping by saturation transfer difference NMR. J Magn Reson 2003, 163:270-6.
-
(2003)
J Magn Reson
, vol.163
, pp. 270-276
-
-
Yan, J.1
Kline, A.D.2
Mo, H.3
-
51
-
-
0034640103
-
Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity
-
Plotnikov AN, Hubbard SR, Schlessinger J. Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity. Cell 2000, 101:413-24.
-
(2000)
Cell
, vol.101
, pp. 413-424
-
-
Plotnikov, A.N.1
Hubbard, S.R.2
Schlessinger, J.3
-
52
-
-
63149141296
-
New insights into the molecular interaction of the C-terminal sequence of CXCL4 with fibroblast growth factor-2
-
Ragona L, Tomaselli S, Quemener C. New insights into the molecular interaction of the C-terminal sequence of CXCL4 with fibroblast growth factor-2. Biochem Biophys Res Commun 2009, 382:26-9.
-
(2009)
Biochem Biophys Res Commun
, vol.382
, pp. 26-29
-
-
Ragona, L.1
Tomaselli, S.2
Quemener, C.3
-
53
-
-
3843136173
-
Platelet factor 4: an inhibitor of angiogenesis
-
Bikfalvi A. Platelet factor 4: an inhibitor of angiogenesis. Semin Thromb Hemost 2004, 30:379-85.
-
(2004)
Semin Thromb Hemost
, vol.30
, pp. 379-385
-
-
Bikfalvi, A.1
|